XAIR

Beyond Air Inc

XAIR, USA

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. In addition, the company develops ultra-high concentration (UNO) that is in Phase 1 clinical trial to treat multiple solid and cutaneous tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions and autism spectrum disorder. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.

https://www.beyondair.net

Stock Price

$ 0.00

0% decrease compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
XAIR
stock
XAIR

Beyond Air (XAIR) Expands LungFit PH Distribution Globally GuruFocus

Read more →
XAIR
stock
XAIR

Tankless hospital breathing tech now reaching 39 countries and 3B people Stock Titan

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

BUY

Target Price:

$10.3333

Analyst Picks

Strong Buy

1

Buy

3

Hold

1

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.46

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-62.36 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-25.64 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-258.47 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Very Low

1.40

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 12.60% of the total shares of Beyond Air Inc

1.

Balyasny Asset Management LLC

(3.1901%)

since

2025/03/31

2.

Lasry Marc

(1.5681%)

since

2025/03/31

3.

Vanguard Group Inc

(1.2098%)

since

2025/03/31

4.

Kingdon Capital Management LLC

(0.8961%)

since

2025/03/31

5.

Vanguard Total Stock Mkt Idx Inv

(0.8234%)

since

2025/07/31

6.

Geode Capital Management, LLC

(0.79%)

since

2025/03/31

7.

Bleichroeder LP

(0.7064%)

since

2025/03/31

8.

Vanguard Institutional Extnd Mkt Idx Tr

(0.5842%)

since

2025/07/31

9.

BlackRock Inc

(0.5252%)

since

2025/03/31

10.

Fidelity Extended Market Index

(0.3944%)

since

2025/07/31

11.

Baldwin Brothers Inc

(0.2947%)

since

2025/03/31

12.

Renaissance Technologies Corp

(0.1877%)

since

2025/03/31

13.

WEALTH EFFECTS LLC

(0.1867%)

since

2025/03/31

14.

Fidelity Total Market Index

(0.1566%)

since

2025/07/31

15.

Advisor Group Holdings, Inc.

(0.123%)

since

2025/03/31

16.

XTX Topco Ltd

(0.1091%)

since

2025/03/31

17.

Spartan Extended Market Index Pool F

(0.0954%)

since

2025/07/31

18.

State Street Corp

(0.0937%)

since

2025/03/31

19.

Northern Trust Corp

(0.0933%)

since

2025/03/31

20.

Fidelity Series Total Market Index

(0.0891%)

since

2025/07/31

21.

Extended Equity Market Fund K

(0.0526%)

since

2025/06/30

22.

Susquehanna International Group, LLP

(0.0489%)

since

2025/03/31

23.

NT Ext Equity Mkt Idx Fd - L

(0.0402%)

since

2025/06/30

24.

Northern Trust Extended Eq Market Idx

(0.0402%)

since

2025/06/30

25.

NT Ext Equity Mkt Idx Fd - NL

(0.039%)

since

2025/06/30

26.

Tower Research Capital LLC

(0.0381%)

since

2025/03/31

27.

UBS Group AG

(0.0379%)

since

2025/03/31

28.

Spartan Total Market Index Pool G

(0.0338%)

since

2025/07/31

29.

Forbes J M & Co

(0.0335%)

since

2025/03/31

30.

NT Ext Equity Mkt Idx Fd - DC - NL - T2

(0.0303%)

since

2025/06/30

31.

BB&T Corp.

(0.023%)

since

2025/03/31

32.

PFS Partners, LLC

(0.0191%)

since

2025/03/31

33.

NT Ext Eq Mkt Indx Fd DC Lending Tier 5

(0.0113%)

since

2025/06/30

34.

NT Ext Eq Mkt Indx Fd DC Lend T3

(0.0096%)

since

2024/12/31

35.

Extended Equity Market Fund M

(0.0066%)

since

2025/06/30

36.

NT Quality SCC US Fund - L

(0.0057%)

since

2025/06/30

37.

NT Quality Small Cap Core

(0.0057%)

since

2025/06/30

38.

SSgA U.S. Total Market Index Strategy

(0.0028%)

since

2025/03/31

39.

Northern Trust Wilshire 5000

(0.002%)

since

2025/06/30

40.

BNYM Mellon SL Market Completion UC1

(0.0017%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

—

EPS Estimate

—

Latest Release

Date

2025-09-30

EPS Actual

-1.25

EPS Estimate

-0.09

EPS Difference

-1.16

Surprise Percent

-1288.8889%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Potential Value Candidate(4.5)
Defensive
Moderately Defensive(6)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
No Clear Moat(2.8)
GARP
Not Attractive for GARP(1.5)
Growth
Weak Growth Prospect(1)
Momentum
Moderate Momentum(3.5)
Net Net
Not Undervalued (Net-Net)(2)
Quality
Low Quality Business(1.5)
Value
Fair Value(4)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.

Beyond Air Inc (XAIR) Stock Details & Analysis - Finnton | Finnton